Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.51 |
| ▸ | MTOR | P42345 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | THRB | P10828 | 1/20 | 0.51 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.51 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.51 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.51 |
| ▸ | GMNN | O75496 | 1/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.51 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.51 |
| ▸ | THPO | P40225 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | BLM | P54132 | 1/20 | 0.51 |
| ▸ | HBB | P68871 | 1/20 | 0.51 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | CDA | P32320 | 1/20 | 0.48 |
| ▸ | PYGM | P11217 | 3/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16631345 | 1.00 | LMNA (0.51) | LMNAMTORALDH1A1THRBMDM2 | |
| SCHEMBL16556356 | 0.90 | CDA (0.42) | LMNAMTORALDH1A1THRBMDM2 | |
| SCHEMBL16631481 | 0.89 | LMNA (0.49) | LMNAMTORALDH1A1THRBMDM2 | |
| SCHEMBL27054170 | 0.88 | TK2 (0.40) | LMNAMTORALDH1A1THRBMDM2 | |
| SCHEMBL27058716 | 0.88 | TK2 (0.40) | LMNAMTORALDH1A1THRBMDM2 | |
| SCHEMBL16631358 | 0.88 | LMNA (0.48) | LMNAMTORALDH1A1THRBMDM2 | |
| SCHEMBL16631418 | 0.86 | CDK1 (0.48) | LMNAMTORALDH1A1THRBMDM2 | |
| SCHEMBL16631305 | 0.86 | LMNA (0.51) | LMNAMTORALDH1A1THRBMDM2 | |
| SCHEMBL21035550 | 0.86 | P2RY6 (0.39) | LMNAMTORALDH1A1THRBMDM2 | |
| SCHEMBL18852429 | 0.86 | LMNA (0.37) | LMNAMTORALDH1A1THRBMDM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 445 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4705481-A2 | CIRCULAR RNA COMPOSITIONS AND METHODS | Orna Therapeutics, Inc. (US) | 2026-03-11 | — | — | EP | claimed |
| WO-2025235365-A1 | METHODS AND SYSTEMS FOR IMPROVED METHYLATION SEQUENCING | FREENOME HOLDINGS, INC. (US) | 2025-11-13 | — | — | WO | claimed |
| EP-4623076-A1 | DOUBLE-STRANDED DNA DEAMINASES AND USES THEREOF | New England Biolabs, Inc. (US) | 2025-10-01 | — | — | EP | claimed |
| WO-2025151711-A1 | NUCLEIC ACID VACCINES TARGETING METHANOGENS | Arkea Bio Corp. (US) | 2025-07-17 | — | — | WO | claimed |
| WO-2025122721-A1 | CHIMERIC PROTEINS AND USES THEREOF | SHATTUCK LABS, INC. (US) | 2025-06-12 | — | — | WO | claimed |
| EP-4554616-A1 | COMPOSITIONS AND METHODS FOR REDUCING METHANE EMISSIONS IN RUMINANT POPULATIONS | Arkea Bio Corp. (US) | 2025-05-21 | — | — | EP | claimed |
| EP-4540415-A1 | METHODS AND COMPOSITIONS FOR THE SIMULTANEOUS IDENTIFICATION AND MAPPING OF DNA METHYLATION | New England Biolabs, Inc. (US) | 2025-04-23 | — | — | EP | claimed |
| WO-2025049610-A1 | MULTI-ACTION PEPTIDES | SHATTUCK LABS, INC. (US) | 2025-03-06 | — | — | WO | claimed |
| CN-113727972-B | Novel hydrazone derivatives having terminal amine groups substituted with aryl or heteroaryl groups and use thereof | 韩国科学技术研究院 | 2024-12-27 | — | — | CN | claimed |
| WO-2024233308-A2 | CIRCULAR RNA COMPOSITIONS AND METHODS | ORNA THERAPEUTICS, INC. (US) | 2024-11-14 | — | — | WO | claimed |
| WO-2024015366-A1 | COMPOSITIONS AND METHODS FOR REDUCING METHANE EMISSIONS IN RUMINANT POPULATIONS | Arkea Bio Corp. (US) | 2024-01-18 | — | — | WO | claimed |
| WO-2023245056-A1 | METHODS AND COMPOSITIONS FOR THE SIMULTANEOUS IDENTIFICATION AND MAPPING OF DNA METHYLATION | NEW ENGLAND BIOLABS, INC. (US) | 2023-12-21 | — | — | WO | claimed |
| WO-2023215498-A2 | COMPOSITIONS AND METHODS FOR CD28 ANTAGONISM | MODERNATX, INC. (US) | 2023-11-09 | — | — | WO | claimed |
| US-20230357838-A1 | Double-Stranded DNA Deaminases and Uses Thereof | NEW ENGLAND BIOLABS, INC. (US) | 2023-11-09 | — | — | US | claimed |
| WO-2023178182-A1 | COMPOSITIONS AND METHODS FOR DETECTION AND TREATMENT OF CORONAVIRUS INFECTION | 10X GENOMICS, INC. (US) | 2023-09-21 | — | — | WO | claimed |
| US-20230257730-A1 | Double-Stranded DNA Deaminases | NEW ENGLAND BIOLABS, INC. (US) | 2023-08-17 | — | — | US | claimed |
| WO-2023097226-A2 | DOUBLE-STRANDED DNA DEAMINASES | NEW ENGLAND BIOLABS, INC. (US) | 2023-06-01 | — | — | WO | claimed |
| WO-2023077156-A1 | MODIFIED MRNA THERAPEUTICS | SHATTUCK LABS, INC. (US) | 2023-05-04 | — | — | WO | claimed |
| WO-2023023055-A1 | COMPOSITIONS AND METHODS FOR OPTIMIZING TROPISM OF DELIVERY SYSTEMS FOR RNA | RENAGADE THERAPEUTICS MANAGEMENT INC. (US) | 2023-02-23 | — | — | WO | claimed |
| CN-109863161-B | Labeled polynucleotides useful for nucleic acid sequencing | 豪夫迈·罗氏有限公司 | 2022-06-03 | — | — | CN | claimed |